Surface‑Engineered Primer Immobilization Enables Simplified and Affordable Nucleic‑Acid Capture for Molecular Diagnostics in Sub‑Saharan Africa

Why It Matters

Eliminating expensive silica extraction reduces consumable costs and equipment needs, expanding affordable molecular testing across sub‑Saharan Africa’s health systems.

Key Takeaways

• Polycarbonate surface treated with acetone‑UV doubles carboxyl groups.
• BPEI linkers attach 2.6× more primers than ethylenediamine.
• One-step solid‑phase capture replaces multi‑buffer silica extraction.
• Process works with phosphate and chaotropic lysis buffers.
• Enables low‑cost, locally produced molecular diagnostics in Africa.

Pulse Analysis

Molecular diagnostics have transformed disease surveillance, but their adoption in sub‑Saharan Africa remains limited by the high cost of nucleic‑acid extraction. Conventional silica‑based kits require multiple wash buffers, magnetic beads, and ethanol, inflating consumable expenses and demanding skilled technicians. Many regional laboratories operate on tight budgets and face supply‑chain disruptions, which hampers timely testing for infections such as malaria, tuberculosis, and emerging viral threats. Reducing the complexity and price of the extraction step is therefore a critical lever for expanding testing capacity across the continent.

The new approach replaces silica with a functionalized polycarbonate substrate that can be fabricated locally using inexpensive acetone and ultraviolet pretreatments. These steps double surface carboxyl density, creating a robust anchor for branched polyethyleneimine (BPEI) linkers. Fluorescence assays show that BPEI‑linked surfaces bind roughly 2.6 times more oligonucleotides than traditional ethylenediamine chemistry, delivering primer densities sufficient for downstream enzymatic reactions. Importantly, the capture chemistry remains effective in both phosphate‑based and chaotropic lysis buffers, demonstrating compatibility with existing sample preparation protocols while eliminating the need for multiple wash steps.

By condensing nucleic‑acid capture into a single solid‑phase step, the technology promises a dramatic reduction in reagent costs and equipment footprints. Local manufacturers can produce the treated polycarbonate plates at scale, leveraging existing plastic‑molding infrastructure and sidestepping import‑heavy silica kits. This affordability opens pathways for broader deployment of point‑of‑care PCR and isothermal assays, potentially accelerating outbreak response and routine disease monitoring. As health ministries evaluate cost‑effective diagnostics, the surface‑engineered primer immobilization could become a cornerstone of sustainable laboratory networks throughout sub‑Saharan Africa.